Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Clinical trial NCT06603311 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06603311
Sponsor: Hannover Medical School
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Compensated Liver Disease (Disorder)Hepatitis D, Chronic

Start date: 2024-09-30
Primary completion: 2026-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.